Steven Gullans
2016
In 2016, Steven Gullans earned a total compensation of $402.9K as Interim President and Chief Executive Officer at NeuroBo Pharmaceuticals.
Compensation breakdown
| Option Awards | $379,062 |
|---|---|
| Other | $23,831 |
| Total | $402,893 |
Gullans received $379.1K in option awards, accounting for 94% of the total pay in 2016.
Gullans also received $23.8K in other compensation.
Rankings
In 2016, Steven Gullans' compensation ranked 11,894th out of 14,075 executives tracked by ExecPay. In other words, Gullans earned more than 15.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,894 out of 14,075 | 16th |
Division Manufacturing | 4,664 out of 5,489 | 15th |
Major group Chemicals And Allied Products | 1,665 out of 1,895 | 12th |
Industry group Drugs | 1,351 out of 1,538 | 12th |
Industry Pharmaceutical Preparations | 1,045 out of 1,176 | 11th |
Source: SEC filing on April 17, 2018.
Gullans' colleagues
We found four more compensation records of executives who worked with Steven Gullans at NeuroBo Pharmaceuticals in 2016.